No.	Product Name	Application	CAS No.	Capacity
1	(1S,4R)-P-MENTHA-2,8-DIEN-1-OL	Cannabidiol Intermediate	22972-51-6	50MT/month
2	methyl 2,4-dihydroxy-6-pentylbenzoate	Cannabidiol Intermediate	58016-28-7	50MT/month
3	ethyl 2,4-dihydroxy-6-pentylbenzoate	Cannabidiol Intermediate	38862-65-6	50MT/month
4	5-pentylbenzene-1,3-diol hydrate	Cannabidiol Intermediate		50MT/month
5	5-pentylbenzene-1,3-diol	Cannabidiol Intermediate	500-66-3	50MT/month
6	Dicyclohexylcarbodiimide	Dehydrating Agent	538-75-0	50MT/month
7	GCLE	Cephalosporin Intermediate	104146-10-3	50MT/month
8	7-ACA	Ceftriaxone Sodium Intermediate	957-68-6	40MT/month
9	Thiotriazinone	Ceftriaxone Sodium Intermediate	58909-39-0	35MT/month
10	7-ACT	Ceftriaxone Sodium Intermediate	131257-07-3	45MT/month
11	2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester	Ceftriaxone Sodium Intermediate	84994-24-1	40MT/month
12	Pyridoxal-5-phosphate monohydrate	P5P/PLP	41468-25-1	5MT/month
13	1-Bromo-3,5-Dimethyladamantane	Menantine Intermediate	941-37-7	1MT/month
14	1,3-Dimethyladamantane	Menantine Intermediate	702-79-4	1MT/month
15	4-Methylenepiperidine.HCl	Efinaconazole Intermediate	144230-50-2	500kg/month
16	(2R,3R)-2-(2,4-difluorophen yl)-1-(1h-1,2,4-triazol- 1-yl)-2,3-butanediol methanesulfonate	Efinaconazole Intermediate	1175536-50-1	500kg/month
17	1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid	Moxifloxacin Intermediate	112811-72-0	1MT/month
18	(1R,6R)-2,8-Diazabicyclo[4,3,0]nonane	Moxifloxacin Intermediate	151213-42-2	1MT/month
19	2,3,4-Trimethoxybenzaldehyde	Trimetazidine Intermediate	2103-57-3	1MT/month
20	2-Nitrobenzaldehyde	Nifedipine Intermediate	552-89-6	5MT/month